by milena henderson | Dec 17, 2025 | Non classé, Quality & Business Excellence
From 13 to 16 October 2025, Pharmalys Founder & CEO Marieme Ba attended the World Vaccine Congress Europe in Amsterdam, one of the most influential global gatherings for vaccine development, innovation, and cross-sector collaboration. This year’s edition brought...
by Veronique Ropion | Oct 29, 2025 | Non classé, Quality & Business Excellence
On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting involved presentations from colleagues, engaging discussions,...
by milena henderson | Oct 16, 2025 | Quality & Business Excellence
In September 2025, the Ecole Supérieure Polytechnique (ESP) Alumni community gathered at the Azalaï Hotel in Dakar, Senegal, to celebrate Alumni Day, a moment to recognise excellence, leadership, and contribution to society. Among the distinguished honourees was...
by milena henderson | Oct 16, 2025 | Non classé, Quality & Business Excellence
In early June, Pharmalys took part in the Epicentre Scientific Day hosted at the Institut Pasteur in Paris. Representing the company, Business Development and Strategic Partnerships Associate Arthur joined researchers, NGOs, and health professionals to engage with the...
by milena henderson | Oct 16, 2025 | Quality & Business Excellence
Before joining Pharmalys, my career was focused on the management of information systems. I began in the financial sector as IT Manager for a financial intermediation company, where I was responsible for building and managing its infrastructure in West Africa. Later,...
by milena henderson | Aug 26, 2025 | Quality & Business Excellence
In June 2025, Marieme Ba, Founder and CEO of Pharmalys, took the stage at the PCMG25 Annual Assembly in Málaga, joining fellow panellists Pierre Brichot (MCT-CRO), Jacqueline Mirera (CREA-N), and Chris Obwanga (IQVIA), in a session chaired by Sandra Johnson. Their...
